Depression Rx Flashcards

1
Q

What is ketamine and what is it classified as?

A

An uncompetitive N-Methyl-D-Aspartate (NMDA) receptor antagonist and dissociative anaesthetic.

It is a racemic mixture of equal amounts of Esketamine and Arketamine or (S)-ketamine and (R)-ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Write about the discovery of ketamine as a Rx option for major depressive disorder

A

In 2000,Berman and colleagues, reported significant findings in a landmark RCT, administering a single dose of 0.5mg/kg ketamine over 40 mins to MDD pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How quickly does ketamine produce a significant antidepressant effect after administration?

A

Within hours after the infusion, increasing progressively up to 3 days after administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two enantiomers of ketamine?

A

Esketamine and arketamine ie (S)-ketamine & (R)-ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which enantiomer of ketamine binds more potently to the NMDA receptor?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What form of use has been approved for use for TRD?

A

The nasal spray formulation of esketamine - Spravato has been approved for TRD in the US and Europe

Otherwise, ketamine remains an off-label rx for TRD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary mechanism proposed for the antidepressant effects of ketamine?

A

Wef 2018 the precise MoA of ketamine in TRD isn’t known but it is proposed that it is d/t Blockade of NMDA Rs on GABAergic interneurons.
These interneurons suppress glutamatergic neurons from releasing glutamate.
Thus the inhibition of this suppression leads to a glutamate surge in the cortex & activation of post-synaptic AMPA Rs thus leading to downstream effects on synaptogenesis & neuroplastic pathways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What neurotransmitter surge is caused by the disinhibition from ketamine’s action?

A

The inhibition of the suppression of the interneurons ie the disinhibition causes a cortical glutamate surge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What receptors are activated downstream of the glutamate surge caused by ketamine?

A

Post-synaptic AMPA receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the gold standard for off-label ketamine administration?

A

IV ketamine (0.5 mg/kg over 40 minutes)
It is available as 50mg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some alternative routes of administration for ketamine that have been proposed?

A
  • Subcutaneous (SC)
  • Intramuscular (IM)
  • Oral
  • Sublingual (SL)
  • Intranasal esketamine ie Spravato
  • Intranasal Ketamine as advised by Andrade et al
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why are routes other than iv not used?

A

Since further research is required to know the safety, efficacy & optimal dosing regimes of other routes.

Also these need more data
* Bioavailability
* Duration of effect
* Practicality
* Patient comfort

While no fixed dosing strategies have been developed Maudsley mentions dosing recommendations based on available evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True or False: There is a fixed dosing strategy established for ketamine across different administration routes.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the dosing strategy advised for Intranasal Ketamine by Andrade et al?

A

Intranasal ketamine with a 1mL dispenser using Ketamine (the same one that’s given iv).
Each puff =1mL = 5mg ketamine maybe administered in alternate nostril w/ a 2-3 mins gap b/w each puff

REMB : not the same as Spravato since that is Esketamine which is given as a bolus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the ADRs patients experience on ketamine ?

A

ADRs patients experience on ketamine at antidepressant doses are
A]. on slow infusion or slow intransal/oral admin: dizziness, nausea, elevation of BP, HR
B]. on fast infusion or rapid oral/ Intranasal admin (e.g.: Spravato or pt mistakenly drinks in a gulp instead of over 15-30mins): dizziness, nausea, dissociative effects, anxiety, transient elevation of BP, HR

CPApp: pt had synesthetic hallucinations- seeing music on gulping dose

edit acc to CP App vid around 1:20:40; at Anesthetic doses there are more S/Es reported as mentioned in the vid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the significant dissociative symptoms associated with ketamine when given at antidepressant doses?

A

Perceptual distortions and significant anxiety though rare if given at the advised regime & dose

These symptoms necessitate reassurance during and after administration.

17
Q

Why is it necessary for patients administered ketamine to be observed by a trained clinician?

A
  • To provide reassurance of the temporary & harmless nature of the dissociative symptoms
  • potential complications like laryngospasm (as per Maudsley, CP App says cardio-resp Cx are unlikely

The observing clinician should be trained in intermediate or advanced life support.

18
Q

What is the recommended observation period after ketamine administration?

A

One hour

as per Maudsley, none as per Andrade lec

19
Q

How does the route of administration affect the likelihood of dissociative symptoms with ketamine?

A

Lower doses given orally or sublingually are less likely to induce strong dissociative symptoms

Hence, after a test dose under supervision, administration may occur in a non-clinical setting.

20
Q

What activities should patients avoid after ketamine administration?

A

Driving, operating heavy machinery, or partaking in high-risk activities
for at least one hour after administration.

21
Q

What should be considered by the prescribing clinician regarding ketamine?

A

The risks of diversion and illegal use

This consideration is crucial for patient safety and legal compliance.

22
Q

What are the recommended physical examinations before administering ketamine?

A

Baseline BP, CBC, LFT
TFT, ECG
help assess the patient’s readiness for ketamine treatment.

Andrade : no baseline Ixs are necessary since the rise in the BP & HR thought maybe over 180 systolic and 90 diastolic, are always transient

23
Q

What should be monitored during and after ketamine administration?

A

Blood pressure and heart rate

24
Q

What is the initial dosing recommendation for IV ketamine administration?

A

0.5 mg/kg, increasing up to 1.0 mg/kg if no response

Titrate from 0.25 mg/kg in older people.

25
Q

What is the frequency of IV ketamine dosing during the induction phase?

A

Once or twice a week

This phase is crucial for establishing the initial therapeutic effect.

26
Q

What is the maintenance phase frequency for ketamine administration?

A

Weekly, then every 2 weeks, or even monthly

This frequency depends on the patient’s response and may include supplemental oral/sublingual doses.

27
Q

What are the potential cognitive effects of ketamine administration?

A

Confusion and dissociation

These effects may occur occasionally during treatment.

28
Q

What cardiovascular effects can ketamine be associated with?

A

Transient increase in blood pressure, tachycardia, and arrhythmias

Pre-treatment ECG is required to monitor these risks.

29
Q

What is the dosing recommendation for subcutaneous (SC) ketamine administration?

A

0.5 mg/kg, increasing up to 1.0 mg/kg if no response

Titrate from 0.25 mg/kg in older people, similar to IV recommendations.

30
Q

What is the administration method for SC ketamine?

A

Bolus injection to an appropriate SC site

This method is less invasive than IV infusion.

31
Q

What is the comment regarding the tolerability of SC ketamine compared to other routes?

A

May be better tolerated than IV or IM routes

Patient response can vary, making individual assessments essential.

32
Q

What is the pharmacological difference in the 2 ketamine enantiomers?

A

Esketamine binds more potently to the NMDA receptor